While the clinicians of Jefferson Health were on the front lines of the battle with COVID-19— treating nearly 16,000 COVID patients and testing 35,000+ people—just behind them were the basic science researchers working hard to understand the molecular and cellular mechanisms driving the disease and the clinician-scientists working to adapt existing therapeutics to the unique challenges created by SARS-CoV-2.
Since early 2020, Jefferson researchers published more than 260 research studies on the coronavirus’s biology and on treatments
"Fast-Paced, Frontline Research,"
Thomas Jefferson University Research Magazine: Vol. 2:
1, Article 7.
Available at: https://jdc.jefferson.edu/researchmagazine/vol2/iss1/7